Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Microbiology and Immunology
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Open Positions
Programs of Study
Our Faculty
Students & Research Fellows
Publications
News and Events
Toggle News and Events menu options
Events
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Our Faculty
Students & Research Fellows
Publications
News and Events
Home
Publications
You are here
Home
>
Publications
>
Publications
Publications
Found 17 results
Author
[
Title
]
Type
Year
Filters:
Author
is
Ketas, Thomas J
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
R Malcolm K
,
Veazey RS
,
Geer L
,
Lowry D
,
Fetherston SM
,
Murphy DJ
,
Boyd P
,
Major I
,
Shattock RJ
,
Klasse PJohan
et al.
. 2012.
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
.
Antimicrob Agents Chemother. 56(5):2251-8.
W Horne S
,
Johnson LM
,
Ketas TJ
,
Klasse PJohan
,
Lu M
,
Moore JP
,
Gellman SH
. 2009.
Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers.
.
Proc Natl Acad Sci U S A. 106(35):14751-6.
R
Anastassopoulou CG
,
Ketas TJ
,
Klasse PJohan
,
Moore JP
. 2009.
Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41.
.
Proc Natl Acad Sci U S A. 106(13):5318-23.
Anastassopoulou CG
,
Ketas TJ
,
Depetris RS
,
Thomas AM
,
Klasse PJohan
,
Moore JP
. 2011.
Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.
.
Virology. 413(1):47-59.
P
Veazey RS
,
Ketas TJ
,
Dufour J
,
Moroney-Rasmussen T
,
Green LC
,
Klasse PJ
,
Moore JP
. 2010.
Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
.
J Infect Dis. 202(5):739-44.
Veazey RS
,
Klasse PJohan
,
Schader SM
,
Hu Q
,
Ketas TJ
,
Lu M
,
Marx PA
,
Dufour J
,
Colonno RJ
,
Shattock RJ
et al.
. 2005.
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
.
Nature. 438(7064):99-102.
N
Dey AK
,
David KB
,
Ray N
,
Ketas TJ
,
Klasse PJ
,
Doms RW
,
Moore JP
. 2008.
N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.
.
Virology. 372(1):187-200.
Pugach P
,
Ketas TJ
,
Michael E
,
Moore JP
. 2008.
Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors.
.
Virology. 377(2):401-7.
I
Pugach P
,
Ray N
,
Klasse PJohan
,
Ketas TJ
,
Michael E
,
Doms RW
,
Lee B
,
Moore JP
. 2009.
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities.
.
Virology. 387(2):296-302.
H
Sanders RW
,
van Gils MJ
,
Derking R
,
Sok D
,
Ketas TJ
,
Burger JA
,
Ozorowski G
,
Cupo A
,
Simonich C
,
Goo L
et al.
. 2015.
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.
.
Science. 349(6244):aac4223.
E
Klasse PJ
,
Ketas TJ
,
Cottrell CA
,
Ozorowski G
,
Debnath G
,
Camara D
,
Francomano E
,
Pugach P
,
Ringe RP
,
LaBranche CC
et al.
. 2018.
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
.
PLoS Pathog. 14(2):e1006913.
Banerjee K
,
Andjelic S
,
Klasse PJohan
,
Kang Y
,
Sanders RW
,
Michael E
,
Durso RJ
,
Ketas TJ
,
Olson WC
,
Moore JP
. 2009.
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.
.
Virology. 389(1-2):108-21.
Ketas TJ
,
Holuigue S
,
Matthews K
,
Moore JP
,
Klasse PJohan
. 2012.
Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.
.
Virology. 422(1):22-36.
Ketas TJ
,
Schader SM
,
Zurita J
,
Teo E
,
Polonis V
,
Lu M
,
Klasse PJohan
,
Moore JP
. 2007.
Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
.
Virology. 364(2):431-40.
C
Ringe RP
,
Pugach P
,
Cottrell CA
,
LaBranche CC
,
Seabright GE
,
Ketas TJ
,
Ozorowski G
,
Kumar S
,
Schorcht A
,
van Gils MJ
et al.
. 2019.
Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
.
J Virol. 93(4)
Dey AK
,
Cupo A
,
Ozorowski G
,
Sharma VK
,
Behrens A-J
,
Go EP
,
Ketas TJ
,
Yasmeen A
,
Klasse PJ
,
Sayeed E
et al.
. 2018.
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.
.
Biotechnol Bioeng. 115(4):885-899.
A
Ingallinella P
,
Bianchi E
,
Ladwa NA
,
Wang Y-J
,
Hrin R
,
Veneziano M
,
Bonelli F
,
Ketas TJ
,
Moore JP
,
Miller MD
et al.
. 2009.
Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.
.
Proc Natl Acad Sci U S A. 106(14):5801-6.